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Abstract
Autism Spectrum Disorder (ASD) is a behavioral
syndrome caused by complex genetic and non-
genetic risk factors. It has been proposed that these
risk factors lead to alterations in the development and
‘wiring’ of brain circuits and hence, the emergence of
ASD. Although several lines of research lend support
to this theory, etiological and clinical heterogeneity,
methodological issues and inconsistent findings have
led to significant doubts. One of the best established,
albeit rare, causes of ASD is the genetic condition
Tuberous Sclerosis Complex (TSC), where 40% of
individuals develop ASD. A recent study by Peters and
Taquet et al. analyzed electroencephalography (EEG)
data using graph theory to model neural
‘connectivity’ in individuals with TSC with and without
ASD and cases with ‘idiopathic’ ASD. TSC cases
exhibited global under-connectivity and abnormal
network topology, whereas individuals with TSC +
ASD demonstrated similar connectivity patterns to
those seen in individuals with idiopathic ASD:
decreased long- over short-range connectivity. The
similarity in connectivity abnormalities in TSC + ASD
and ASD suggest a common final pathway and
provide further support for ‘mis-wired’ neural circuitry
in ASD. The origins of the connectivity changes, and
their role in mediating between the neural and the
cognitive/behavioral manifestations, will require
further study.
Please see related research article here http://www.
biomedcentral.com/1741-7015/11/54
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Background
The recent and rapid rise in the prevalence of Autism
Spectrum Disorder (ASD) has fuelled intensive research
into the causes and neurobiological basis of ASD, with
major advances in identifying the genetic factors involved
[1]. Nevertheless, the findings have revealed considerable
etiological heterogeneity and marked variability in pheno-
typic expression, which has led to uncertainty as to
whether there exist several different subtypes of ASD or
whether the causal factors converge in a final common
pathway. Accordingly, molecular genetic research has
begun not just to study the genetic variants associated
with the clinical phenotype of ASD, but also the associa-
tion with neurobiological processes that may underlie the
complex behavioral profile. The challenge of disentangling
the heterogeneity of ASD has also led to an increasing rea-
lization that important insights can be gained from the
study of the established genetic causes of ASD, where the
pathophysiology is better understood and more tractable
to study [2]. Importantly, in most of the genetic syn-
dromes associated with ASD, only a subset of individuals
actually develop ASD, providing a valuable opportunity to
investigate the causal pathways leading to the variation in
outcome. The dramatic advances in understanding the
molecular mechanisms underlying fragile × syndrome and
Tuberous Sclerosis Complex (TSC; two of the best estab-
lished causes of ASD [3]) and the concomitant and excit-
ing advances in drug therapies for these conditions, have
highlighted the importance of these model systems for
understanding whether and how ASD develops and if, as
pre-clinical studies suggest, cognitive and behavioral out-
comes are improved by the novel therapies [4]. At present,
the etiological mechanisms underlying the co-occurrence
of ASD in genetic syndromes, and the extent and depth of
‘homology’ in phenotypic manifestations of ASD in genetic
syndromes compared with idiopathic cases of ASD,
remain unclear.
In this context, the report by Peters and Taquet et al.
[5] in BMC Medicine holds special interest. The study
exploits recent advances in brain science to investigate
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the structure and integrity of neural connections and
networks: the results are striking in showing that the
perturbations in neural connectivity observed in indivi-
duals with TSC and co-occurring ASD parallel those
observed in cases of idiopathic ASD, indicating that
there is some ‘homology’ in the nature of the connectiv-
ity abnormalities and pointing to common pathophysio-
logical processes.
The mis-wired brain
In parallel with the increasing awareness that the brain
operates in a complex and dynamic manner, evidence is
accumulating to suggest that altered neural connectivity,
rather than a specific and localized deficit, underlies
many complex psychiatric disorders [6]. The advent of
methodological and analytical advances has allowed the
examination of brain connectivity in vivo. Their applica-
tion to brain data in ASD has led to the suggestion that it
is a developmental disconnection syndrome [7], charac-
terized by ‘local over-connectivity and long-distance
under-connectivity’ [8]. Graph theory provides a quanti-
tative framework to examine connections of the brain
defined by a collection of brain regions (nodes) and the
connections between them (edges) (see Peters and
Taquet et al. [5] and [9]). Aberrant connectivity across
different modalities is widely reported in ASD: findings
support reduced functional connectivity measured using
magnetic resonance imaging (MRI), reduced fractional
anisotropy (FA) as an index of structural connectivity
using diffusion tensor imaging (DTI), and altered yet
inconsistent connectivity findings using electroencepha-
lography/magnetoencephalography (EEG/MEG; see [10]
for comprehensive review). Peters and Taquet et al. [5]
show a decreased ratio of long- over short-range coher-
ence in ASD, suggesting that local brain regions commu-
nicate via strong connections compared to long-range
paths, although with no significant differences in func-
tional graph theoretical measures.
Previous results differ with respect to the regions in
which aberrant connectivity has been observed, age of the
participants and connectivity patterns during resting state
versus task-dependent paradigms. Moreover, the differ-
ences in findings may also reflect the heterogeneity of
ASD. Accordingly, a focus on a simpler model of ASD,
such as TSC, holds the promise of being especially infor-
mative. In contrast to ASD, Peters and Taquet et al. [5]
report a more widespread network dysfunction in TSC,
with decreased global efficiency and local connectivity
and, as a result, closer to the classic definition of a ‘discon-
nection syndrome’. Findings suggest, therefore, that abnor-
mal connectivity patterns are associated with these
disorders, yet the basis for these abnormalities is unknown,
for example, whether they involve the whole brain or spe-
cific brain regions. In addition, whether or not these
findings depend on the frequency band studied, given the
varied associations between frequency and cognition is of
interest. The Peters and Taquet et al. [5] study focused on
alpha and theta bands, and it would be useful to investi-
gate gamma activity considering its hypothesized role in
neural synchronization [11].
Targeting the common pathway
While it appears likely that in most cases there are multi-
ple risk pathways to ASD, it is possible that these path-
ways converge at some level, with network efficiency
providing a potential platform. As such, system-level con-
cepts may simplify and merge the diverse genetic
mechanisms identified for ASD. One hypothesis is a
greater ratio of excitatory versus inhibitory connections
in the brain networks in ASD, supported by hyper-con-
nectivity in frontal brain regions, elevated gamma fre-
quency and an increased risk of seizures [12]. In addition,
many autism susceptibility genes are linked to activity-
dependent neural responses, supporting the emerging
claim that ASD is a disorder of the synapse [13]. A recent
hypothesis for the emergence of ASD in TSC and related
conditions is dysregulation of neurotrophic factors,
including brain-derived neurotrophic factor (BDNF)
which plays a role in protein regulation through inhibi-
tion of TSC1-TSC2 signaling and mutations in PTEN
that lead to excessive mammalian Target of Rapamycin
(mTOR) signaling. It is suggested that these processes
alter the development of inhibitory synapses and synaptic
plasticity, ultimately resulting in syndromic ASD [13].
An important finding from Peters and Taquet et al. [5]
is that despite methodological limitations, the connectivity
abnormalities associated with ASD were confined to the
subset of TSC + ASD cases, which suggests that there may
be distinct risk factors for ASD in TSC. This highlights the
need to investigate the interplay between risk factors
[14,15]. Beyond the molecular and synaptic level, the
research has also to account for the raised risk of ASD fol-
lowing infantile spasms (a form of epilepsy) in cases of
TSC. While these observations provide insight into the
mechanisms underlying autism in the context of TSC,
being able to identify the common pathway would also
facilitate improved treatment across a range of different
causes of ASD, and provide a model for other Mendelian
disorders [16]. It is important not to oversimplify, how-
ever, and to recognize that targeting dysregulation in one
pathway may potentially worsen outcomes in cases that
are due to abnormalities in other paths, as has recently
been shown in animal models of TSC and fragile × syn-
drome [17].
A developmental perspective
An important outstanding question is whether the con-
nectivity abnormalities reflect earlier developmental and
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compensatory processes. As such, studies of the emer-
gence, maturation and developmental sequences in con-
nectivity and associated network properties are required,
especially as there are such vast age-related changes in
EEG. In particular, it is unclear whether the altered
connectivity patterns occur pre- and/or post-natally and
reflect deterioration of already established connections
or a failure in the formation of connections. Some find-
ings suggest over-connectivity at a young age and
under-connectivity at older ages in ASD, which may
reflect impaired synaptic pruning (and therefore over-
growth) during brain development [10]. For example, by
occupying sites normally available, the exuberance of
axons over shorter distances may restrict longer distance
connections, which develop later and need additional
time to grow [18]. As such, the increased resilience to
‘targeted attack’ in ASD reported in Peters and Taquet
et al. [5] may reflect this redundant over-connectivity or
reduced functional specialization at younger ages.
Accordingly, treatments targeting dysfunction in excita-
tory systems may be effective in early development,
whereas later it may be necessary to also treat the ensu-
ing alterations to neural networks. Quantitative mea-
sures, such as those derived from graph theory, may
therefore be used as biomarkers for early detection, to
inform prognosis, and to allow the formation of more
homogenous groups based on emergence and persis-
tence of key behavior and brain markers [19].
Conclusions
The study by Peters and Taquet et al. [5] exemplifies
the insights that can be gleaned from studying rare
genetic disorders to elucidate etiological pathways in
complex psychiatric disease, as well as the use of state-
of-the-art neuroscience techniques to map abnormalities
in brain function. The findings are advancing our under-
standing of the neurobiology of ASD. More research of
this kind is needed, and the results of their prospective
studies will be eagerly awaited.
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